Impax Wants Goodwin Procter Barred In Teva Contract Fight
Impax Laboratories, which is facing contract claims from Teva Pharmaceuticals over the antidepressant drug Budeprion, argued in Pennsylvania state court Tuesday that Goodwin Procter LLP can't represent Teva in the litigation...To view the full article, register now.
Already a subscriber? Click here to view full article